# Cyclobenzaprine Hydrochloride

NDC: 0904-7400
Generic name: Cyclobenzaprine Hydrochloride
Labeler / Manufacturer: Major Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20080926
Marketing ended: 20270131
FDA application: ANDA078643

## Active ingredients

- CYCLOBENZAPRINE HYDROCHLORIDE: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0904-7400"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0904-7400
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=508e310e-067a-4f95-869a-e1da49aabe94
